Julie Ritchey

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma”.

Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma

European Journal of Nuclear Medicine and Molecular Imaging(2020)10.1007/s00259-020-05097-y

N/A

0DataRank · unranked

19 citations

Alexander Zheleznyak, Matt Mixdorf, Julie O’Neal, Julie Ritchey, Michael P. Rettig +4 more

Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient

Blood Advances(2020)10.1182/bloodadvances.2019000664

N/A

0DataRank · unranked

14 citations

Michael P. Rettig, Phil Powell, Kathryn O’Brien, David B. Clifford, Julie Ritchey +9 more

VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2839

N/A

0DataRank · unranked

27 citations

Michael J. Scott, John S. Allen, Xiaoxia Yang, Grace Cui, Dipanjan Pan +12 more

CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy

JCI Insight(2021)10.1172/jci.insight.149819

N/A

0DataRank · unranked

40 citations

Matthew Cooper, Miriam T. Jacobs, Julie Ritchey, Julia Hollaway, Todd A. Fehniger +2 more

Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation

Journal of Clinical Investigation(2021)10.1172/jci145501

N/A

0DataRank · unranked

29 citations

Julie Ritchey, Sena Kim, Sora Lim, Peter Ruminski, Matthew Cooper +4 more

A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1872068

N/A

0DataRank · unranked

8 citations

Michael P. Rettig, Theresa Fletcher, Julie Ritchey, Leah Gehrs, Kyle McFarland +15 more

A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity

Nature Communications(2022)10.1038/s41467-022-30860-0

N/A

0DataRank · unranked

97 citations

Reyka G. Jayasinghe, Jessica M. Devenport, Julie Ritchey, Michael P. Rettig, Julie O’Neal +8 more

CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells

Leukemia(2022)10.1038/s41375-022-01559-4

N/A

0DataRank · unranked

55 citations

Julie Ritchey, Matthew Cooper, Jessica Niswonger, Luisalberto Gonzalez, Emily Street +12 more

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

Scientific Reports(2022)10.1038/s41598-021-03748-0

N/A

0DataRank · unranked

23 citations

Chantiya Chanswangphuwana, Nicholas S. Cho, Francesca Fontana, Dolonchampa Maji, Julie Ritchey +10 more

Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy

Journal of Cellular and Molecular Medicine(2022)10.1111/jcmm.16885

N/A

0DataRank · unranked

15 citations

Jennifer Sun, Barbara Muz, Amanda Jeske, Julie O’Neal, Julie Ritchey +4 more

S100A9 upregulated by IFNGR signaling blockade functions as a novel GVHD suppressor without compromising GVL in mice

Blood(2022)10.1182/blood.2021012687

N/A

0DataRank · unranked

5 citations

Sora Lim, Boram Kim, Julie Ritchey, Kiran Vij, Julie L. Prior +8 more

An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies

Leukemia(2023)10.1038/s41375-023-02039-z

N/A

0DataRank · unranked

39 citations

Jessica M. Devenport, Alun Carter, Karl Staser, Miriam Kim, Julie O’ Neal +9 more

Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc

Blood Advances(2023)10.1182/bloodadvances.2023010032

N/A

0DataRank · unranked

27 citations

Matthew Cooper, Julie Ritchey, Susan Gladney, Jessica Niswonger, Luisalberto Gonzalez +13 more

Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization

Blood Advances(2024)10.1182/bloodadvances.2023011653

N/A

0DataRank · unranked

15 citations

Michael P. Rettig, Darja Karpova, Haresh Thakellapalli, Megh Singh, Marvin J. Meyers +9 more

Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors

Cancer Discovery(2024)10.1158/2159-8290.cd-23-1393

N/A

0DataRank · unranked

10 citations

Jack H. Landmann, Tien-Ching Chang, Mehmet Emrah Selli, Yangdon Tenzin, John M. Warrington +8 more

Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager

PLoS ONE(2024)10.1371/journal.pone.0300174

N/A

0DataRank · unranked

5 citations

Julie Ritchey, Michael P. Rettig, Dilan A. Patel, Kiran Vij, Feng Gao +4 more

Conditioning with anti-CD47 and anti-CD117 plus JAK inhibition enables toxic payload-free allogeneic transplantation

Blood Advances(2024)10.1182/bloodadvances.2023012457

N/A

0DataRank · unranked

3 citations

Aditya R. Yelamali, Julie Ritchey, John F. Dipersio, Stephen P. Persaud

Streptavidin-drug conjugates streamline optimization of antibody-based conditioning for hematopoietic stem cell transplantation

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.12.579199

N/A

0DataRank · unranked

2 citations

Ezhilarasi Chendamarai, Julie Ritchey, Michael P. Rettig, John F. Dipersio, Stephen P. Persaud +1 more

Targeting CD117 on hematopoietic stem and progenitor cells impairs CAR T cell activity

Molecular Therapy(2025)10.1016/j.ymthe.2025.05.033

N/A

0DataRank · unranked

7 citations

Julie Ritchey, John F. Dipersio, Miriam Kim, Riedl Thomas

Streptavidin-drug conjugates streamline optimization of antibody-based hematopoietic stem cell transplant conditioning

Blood Immunology & Cellular Therapy(2025)10.1016/j.bict.2025.100012

N/A

0DataRank · unranked

0 citations

Ezhilarasi Chendamarai, Julie Ritchey, Michael P. Rettig, John F. Dipersio, Stephen P. Persaud +1 more